Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 10, 2025 09:16 ET | Source: Transparency Market Research

PCSK9 Inhibitor Market Growth Accelerates to USD 9.3 Billion by 2034, Driven by Innovative Cholesterol-Lowering Solutions | Latest Report by Transparency Market Research, Inc.

Wilmington, Delaware, United States, Transparency Market Research Inc.-, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The PCSK9 Inhibitor Market (Markt für PCSK9-Inhibitoren) is poised for significant growth,...
November 20, 2024 10:03 ET | Source: Research and Markets

Ischemic Heart Disease (IHD) Drugs Strategic Research Report 2024: Market to Grow by $1.1 Billion During 2023-2030, Driven by Increasing Demand for Combination Therapies

Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease (IHD) Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
March 17, 2017 10:29 ET | Source: National Lipid Association

FOURIER Trial Reveals Significant Reduction in Cardiovascular Risk

WASHINGTON, DC--(Marketwired - March 17, 2017) - The FOURIER trial lead investigators announced today that the PCSK9 inhibitor evolocumab significantly reduced the risk of cardiovascular events by...